Featured Research

from universities, journals, and other organizations

New Blood Test Can Diagnose And Monitor Treatment Of Parkinson's Disease

Date:
April 27, 2007
Source:
Howard Florey Institute
Summary:
A simple test to diagnose Parkinson's disease before symptoms appear by measuring the levels of a protein in blood is being developed by Australian researchers.

A simple test to diagnose Parkinson's disease (PD) before symptoms appear by measuring the levels of a protein in blood is being developed by researchers from the Howard Florey Institute, The University of Melbourne and The Mental Health Research Institute of Victoria.

Related Articles


While Florey researchers have also created a genetic test for PD (10% of PD cases are caused by genetic factors), this new test has a broader application by screening for many different types of PD and monitoring treatment, as well as measuring the effectiveness of drugs being developed to treat the disease.

Dr Qiao-Xin Li and colleagues from The University of Melbourne and The Mental Health Research Institute of Victoria, along with Prof Malcolm Horne from the Howard Florey Institute, found people with PD had low levels of the brain-secreted protein 'alpha-synuclein' in their blood, while people without PD had high levels of the protein.

Prof Horne said the test they developed measured alpha-synuclein levels in blood. "Currently there is no specific PD diagnostic test so doctors rely on their observations to make a diagnosis, which means some patients may not be prescribed the most suitable medication and around 15% of those diagnosed may actually be suffering from something else," Prof Horne said.

"Further studies are required to establish whether this test can distinguish between people who are responsive to treatment and those who are not," he said. The researchers are now conducting a large-scale study to determine the effectiveness of the test, to discover whether it is applicable for all types of PD, and to find out if it can measure the rate of progression and severity of the disease. "If the results of our large-scale study are encouraging, this test could be available for clinical use within the next two years," Prof Horne said.

"We are now refining the test to make it quicker and cheaper so it can be offered to all those who have or are at risk of developing PD. "While the clinical outcomes for this test will be significant, it also opens up new avenues of PD research and drug development.

"Further research using this test will also help us better understand the many different forms of PD and work towards ways to prevent or delay the disease. "The test will also ensure drug trial participants actually have PD so research outcomes will be statistically more valid, which paves the way for faster and more effective drug development.

"When drugs that modify disease progression are available, this test may also help in showing whether candidate drugs are having an effect on the disease by keeping alpha-synuclein levels close to normal," Prof Horne said.

This research was recently published in Experimental Neurology and was a collaborative project involving Qiao-Xin Li, Su San Mok, Katrina Laughton, Catriona McLean, Roberto Cappai, Colin Masters, Janetta Culvenor and Malcolm Horne.

About Parkinson's Disease

Parkinson's disease (PD) is the second most common neurodegenerative disorder affecting 1% of the Australian population over the age of 65. Parkinson's is second only to dementia as the most common chronic neurological condition. 80,000 Australians have Parkinson's and 4,000 are diagnosed each year. 20,000 Victorians have Parkinson's, and over 1,000 are diagnosed each year, or nineteen each week. The direct and indirect costs of Parkinson's to the state of Victoria are over one billion dollars per year. This will significantly increase in the next thirty years with the ageing of the population. There is a misconception that this is an "old person's" disease. 20% of people with the disease are under 50 when diagnosed.


Story Source:

The above story is based on materials provided by Howard Florey Institute. Note: Materials may be edited for content and length.


Cite This Page:

Howard Florey Institute. "New Blood Test Can Diagnose And Monitor Treatment Of Parkinson's Disease." ScienceDaily. ScienceDaily, 27 April 2007. <www.sciencedaily.com/releases/2007/04/070426093416.htm>.
Howard Florey Institute. (2007, April 27). New Blood Test Can Diagnose And Monitor Treatment Of Parkinson's Disease. ScienceDaily. Retrieved October 30, 2014 from www.sciencedaily.com/releases/2007/04/070426093416.htm
Howard Florey Institute. "New Blood Test Can Diagnose And Monitor Treatment Of Parkinson's Disease." ScienceDaily. www.sciencedaily.com/releases/2007/04/070426093416.htm (accessed October 30, 2014).

Share This



More Health & Medicine News

Thursday, October 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Reuters - Innovations Video Online (Oct. 29, 2014) A Swedish amputee who became the first person to ever receive a brain controlled prosthetic arm is able to manipulate and handle delicate objects with an unprecedented level of dexterity. The device is connected directly to his bone, nerves and muscles, giving him the ability to control it with his thoughts. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Google To Use Nanoparticles, Wearables To Detect Disease

Google To Use Nanoparticles, Wearables To Detect Disease

Newsy (Oct. 29, 2014) Google X wants to improve modern medicine with nanoparticles and a wearable device. It's all an attempt to tackle disease detection and prevention. Video provided by Newsy
Powered by NewsLook.com
Can Drinking Milk Lead To Early Death?

Can Drinking Milk Lead To Early Death?

Newsy (Oct. 29, 2014) Researchers in Sweden released a study showing heavy milk drinkers face an increased mortality risk from a variety of causes. Video provided by Newsy
Powered by NewsLook.com
Obama: The US Will Not 'run and Hide' From Ebola

Obama: The US Will Not 'run and Hide' From Ebola

AP (Oct. 29, 2014) Surrounded by health care workers in the White House East Room, President Barack Obama said the U.S. will likely see additional Ebola cases in the weeks ahead. But he said the nation can't seal itself off in the fight against the disease. (Oct. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins